Testing delivered through medical institutions
Genetic tests are provided through medical institutions, supporting informed consent, clinical result consultation and appropriate follow-up.
Healthcare & Laboratory
OASIS HEALTHCARE & LABORATORY
Genetic testing,
built for trusted
medical decisions.
In-house laboratory operations and a high-throughput laboratory under development in Fukuoka.
OASIS is building a healthcare platform that takes responsibility for the testing workflow.
OWN LAB / IN OPERATIONOASIS Laboratory
In-house management of genetic testing and analytical workflows
UNDER DEVELOPMENTFukuoka High-throughput Lab
A high-throughput testing laboratory under development in Fukuoka
OUR PURPOSE
Supporting the decisions
that follow every result.
OASIS is a Fukuoka-based healthcare company providing genetic testing, laboratory development and medical travel support. We view informed consent, specimen management, reporting and clinical communication as integral parts of testing quality.
Our laboratory platform →Laboratory workflows managed in-house
OASIS manages testing and analytical workflows through its own laboratory, with an emphasis on traceability from specimen to report.
A high-throughput laboratory in Fukuoka
We are developing a local laboratory designed to support domestic specimen intake, high-throughput analysis and reporting.
OASIS HEALTH
Genetic and molecular testing
From prenatal and reproductive screening to cancer genomics and healthy-ageing analysis. Each page explains the purpose, specimen, analytical scope and limitations of the test.
PRENATAL SCREENING01
NIFTY® / NIFTY® Pro
Non-Invasive Prenatal Testing (NIPT)
A prenatal screening test that analyses cell-free fetal DNA in maternal blood to assess the chance of selected chromosomal conditions.
View details →
REPRODUCTIVE GENETICS02
VISTA™
Carrier Screening
Carrier screening assesses whether a person carries selected genetic variants associated with inherited conditions, even when they have no symptoms.
View details →
GERMLINE TESTING03
Hereditary Cancer
Hereditary Cancer Risk Testing
A germline genetic test that assesses selected inherited variants associated with hereditary cancer syndromes and supports clinical risk-management discussions.
View details →
TUMOR GENOMICS04
SENTIS™ Cancer + Discovery
Comprehensive Cancer Genomic Profiling
A tumor profiling test that analyses tumor tissue or circulating tumor DNA and organises genomic findings relevant to treatment and clinical-trial discussions.
View details →
HEALTH & LONGEVITY05
OASIS BioAge
DNA Methylation BioAge Analysis
A wellness analysis that uses DNA methylation patterns to visualise biological age and other age-related indicators.
View details →For medical institutions
Request forms, consent materials, collection kits, transport instructions and report samples are available during implementation.
Discuss implementation ↗
OASIS LAB / FUKUOKAOASIS LAB
In-house operations,
with the next platform in Fukuoka.
OASIS currently manages genetic testing and analytical workflows through its own laboratory. In Fukuoka, we are developing a high-throughput laboratory intended to support a domestic workflow from specimen receipt through reporting.
01 / IN OPERATIONOASIS Laboratory
Testing, genomic analysis and bioinformatics
02 / IN DEVELOPMENTFukuoka High-throughput Laboratory
Domestic intake, scalable analysis and reporting workflows
OASIS NETWORK
Connecting testing with access to care
BIOAGE ADOPTION / 2 CLINICS
→Medical Network
OASIS BioAge has been introduced at Ochanomizu Health and Longevity Clinic and FSC Fukuoka St. Friends Clinic.
MEDICAL TRAVEL SUPPORT
→OASIS Life
Coordination with medical institutions, medical-stay visa support, transport, interpretation and pre- and post-visit assistance.
COMPANY
Company profile
- Company
- OASIS Co., Ltd.
- Head office
- Room 213, West 5 Building, 744 Motooka, Nishi-ku, Fukuoka, Japan
- Business areas
- OASIS Health / laboratory development / medical travel support
- Contact
- info@oasis-nippon.com